Bayer Healthcare LLC

Ascensia Diabetes Care Holdings Ag

Bayer Corporation

Miles Inc.

Mary Ellen Warchal-Windham

Amy H Chu

Andrew J Dosmann

Christine D Nelson

Karen L Marfurt

Boru Zhu

Brenda L Tudor

Huan-Ping Wu

Steven C Charlton

Joel M Blatt

Bern Everett Harrison

Christina Blaschke

Bert Walter

Nicole D Ellis

Mark S Vreeke

Howard A Cooper

Brenda Tudor

Barbara J Mikel

Devices and methods for determining one or more analyte concentrations in a sample, determining a sample type, and/or accounting for interference species in a sample are disclosed that include intertwining a first input signal, via a first electrode having a reagent, with a second input signal, via a second electrode lacking a reagent, by applying to the sample the first input signal having at least two excitations and a relaxation, and applying to the sample the second input signal having at least two excitations and a relaxation, such that the excitations of the first input signal are nonconcurrent with the excitations of the second input signal. The method further includes measuring a first output signal responsive to the first input signal and a second output signal responsive to the second input signal.

Intertwined electrical input signals

A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.

Reagents and methods for detecting analytes

A biosensor system for determining the concentration of an analyte in a sample includes a plurality of test sensors, and includes a container including a desiccant and the plurality of test sensors, sealed in the container. When the container is stored for two weeks at a temperature of 50&#xb0; C., and each test sensor is subsequently removed from the container, connected through the at least two conductors to a measurement device and then contacted with one of a plurality of samples including an analyte, where the plurality of samples has analyte concentrations that span the range of 50 mg/dL-600 mg/dL, and the analyte concentration in each sample is determined by the test sensor and the measuring device, the bias of each determined analyte concentration may be within &#xb1;10 mg/dL or &#xb1;10%, and the coefficient of variation of the determined analyte concentrations may be at most 2.5%.

Biosensor desiccant system having enhanced measurement performance

A total transmission spectroscopy system for use in determining the analyte concentration in a fluid sample comprises a sample cell receiving area, a light source, a collimating lens, a first lens, a second lens, and a detector. The sample cell receiving area is adapted to receive a sample to be analyzed. The sample cell receiving area is constructed of a substantially optically clear material. The collimating lens is adapted to receive light from the light source and adapted to illuminate the sample cell receiving area with a substantially collimated beam of light. The first lens is adapted to receive regular and scattered light transmitted through the sample at a first angle of divergence. The first lens receives light having a first angle of acceptance. The first lens outputs light having a second angle of divergence. The second angle of divergence is less than the first angle of divergence. The second lens is adapted to receive light from the first lens and adapted to output a substantially collimated beam of light. The detector is adapted to measure the light output by the second lens.

Method of determining glucose concentration of a whole blood sample

The glucose content of blood can be determined by contacting a blood sample with a test strip containing a glucose dehydrogenase dependent on PQQ (or derivatives or isomers) thereof as a co-factor, a tetrazolium salt indicator, but in the absence of a mediator.

Determining the concentration of analytes in sample by direct mediation of enzymes

Method for determining an analyte concentration in a fluid

Transmission spectroscopy system for use in the determination of analytes in body fluid

Reagents for detecting an analyte are described. A reagent comprises (a) an enzyme selected from the group consisting of a flavoprotein, a quinoprotein, and a combination thereof; and (b) a mediator selected from the group consisting of a phenothiazine, a phenoxazine, and a combination thereof. In addition, reagents having good stability to radiation sterilization are described. Electrochemical sensors and sampling devices comprising such reagents, methods of producing a sterilized device including such reagents, and methods for detecting an analyte which utilize such reagents are described as well.

Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes

Growing community of inventors

Osceola, IN, United States of America

Mary Ellen Warchal-Windham